Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of The Therapeutic Benefits of Nigella Sativa in Children With Beta Thalassemia Major

NCT02816957 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT02816957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of The Therapeutic Benefits of Nigella Sativa in Children With Beta Thalassemia Major
Lead sponsor
Tanta University
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2016
Completion date
June 30, 2017
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nigella sativa with beta thalassemia major